AGUIAR JÚNIOR, P.; BARRETO, C. M. N.; ROITBERG, F.; LOPES JÚNIOR, G.; DEL GIGLIO, A. Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study. São Paulo Medical Journal, [S. l.], v. 137, n. 6, p. 505–511, 2019. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/999. Acesso em: 17 oct. 2025.